No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs142560630 |
chr4:118248994-118248995 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs75176725 |
chr4:118248998-118248999 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs374347079 |
chr4:118249033-118249034 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs183121495 |
chr4:118249093-118249094 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs188598729 |
chr4:118249124-118249125 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs540324770 |
chr4:118249194-118249195 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs74688685 |
chr4:118249209-118249210 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs533584143 |
chr4:118249213-118249214 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs370531733 |
chr4:118249222-118249223 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs553448458 |
chr4:118249241-118249242 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs573402928 |
chr4:118249260-118249261 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs542373071 |
chr4:118249277-118249278 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs5861343 |
chr4:118249313-118249314 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs150958558 |
chr4:118249439-118249440 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs576228315 |
chr4:118249459-118249460 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs545264320 |
chr4:118249510-118249511 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs565065599 |
chr4:118249626-118249627 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs527674522 |
chr4:118249634-118249635 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs192989885 |
chr4:118249661-118249662 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs576806277 |
chr4:118249662-118249663 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs62313485 |
chr4:118249707-118249708 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs546204105 |
chr4:118249716-118249717 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs561328274 |
chr4:118249722-118249723 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs142497246 |
chr4:118249781-118249782 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs144839800 |
chr4:118249791-118249792 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs79144216 |
chr4:118249841-118249842 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs147949453 |
chr4:118249859-118249860 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs552826860 |
chr4:118249870-118249871 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs141836590 |
chr4:118249897-118249898 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs150492865 |
chr4:118249911-118249912 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs185684828 |
chr4:118249912-118249913 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs373671155 |
chr4:118249923-118249924 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs112072638 |
chr4:118249941-118249942 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs115411792 |
chr4:118249948-118249949 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs72681342 |
chr4:118250069-118250070 |
Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs564490324 |
chr4:118250076-118250077 |
Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs35884465 |
chr4:118250114-118250115 |
Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs187914492 |
chr4:118250134-118250135 |
Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs572381434 |
chr4:118250141-118250142 |
Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs541404196 |
chr4:118250155-118250156 |
Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs560195944 |
chr4:118250193-118250194 |
Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs561291466 |
chr4:118250474-118250475 |
Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs530148963 |
chr4:118250484-118250485 |
Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs543883412 |
chr4:118250513-118250514 |
Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs563673622 |
chr4:118250560-118250561 |
Active TSS Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs35365751 |
chr4:118250606-118250607 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs532738367 |
chr4:118250654-118250655 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs76416250 |
chr4:118250662-118250663 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs138142615 |
chr4:118250698-118250699 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs73856323 |
chr4:118250810-118250811 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|